Accumulation of herpes simplex virus type 1 early and leaky-late proteins correlates with apoptosis prevention in infected human HEp-2 cells.
about
Herpes simplex virus ICP27 protein directly interacts with the nuclear pore complex through Nup62, inhibiting host nucleocytoplasmic transport pathwaysAssociation of herpes simplex virus type 1 ICP8 and ICP27 proteins with cellular RNA polymerase II holoenzymeHerpes simplex virus type 1 immediate-early protein ICP27 is required for efficient incorporation of ICP0 and ICP4 into virionsThe herpes simplex virus type 1 vhs-UL41 gene secures viral replication by temporarily evading apoptotic cellular response to infection: Vhs-UL41 activity might require interactions with elements of cellular mRNA degradation machinery.Herpes simplex virus type 1 (HSV-1)-induced apoptosis in human dendritic cells as a result of downregulation of cellular FLICE-inhibitory protein and reduced expression of HSV-1 antiapoptotic latency-associated transcript sequences.HSV-1 ICP27 induces apoptosis by promoting Bax translocation to mitochondria through interacting with 14-3-3θ.Viral and cellular mRNA-specific activators harness PABP and eIF4G to promote translation initiation downstream of cap bindingThe suppression of apoptosis by α-herpesvirus.Herpes simplex virus ICP27 activation of stress kinases JNK and p38.The dominant-negative herpes simplex virus type 1 (HSV-1) recombinant CJ83193 can serve as an effective vaccine against wild-type HSV-1 infection in mice.Regions of the herpes simplex virus type 1 latency-associated transcript that protect cells from apoptosis in vitro and protect neuronal cells in vivo.Mapping of functional regions in the amino-terminal portion of the herpes simplex virus ICP27 regulatory protein: importance of the leucine-rich nuclear export signal and RGG Box RNA-binding domain.Herpes simplex virus ICP27 is required for virus-induced stabilization of the ARE-containing IEX-1 mRNA encoded by the human IER3 geneNF-kappaB is required for apoptosis prevention during herpes simplex virus type 1 infectionHerpes simplex virus infection and apoptosis.HSV LAT and neuronal survival.Herpes simplex virus 1 gene products occlude the interferon signaling pathway at multiple sites.Herpes simplex virus type 1 ICP27 induces p38 mitogen-activated protein kinase signaling and apoptosis in HeLa cells.Langerhans cells and viral immunity.Clinical and molecular aspects of varicella zoster virus infection.Efficient replication by herpes simplex virus type 1 involves activation of the IkappaB kinase-IkappaB-p65 pathway.Viruses and Langerhans cells.The many roles of the highly interactive HSV protein ICP27, a key regulator of infection.Early passage neonatal and adult keratinocytes are sensitive to apoptosis induced by infection with an ICP27-null mutant of herpes simplex virus 1.Herpes simplex virus type 1 ICP27-dependent activation of NF-kappaB.CK2 protein kinase is stimulated and redistributed by functional herpes simplex virus ICP27 proteinVaricella-zoster virus-infected human sensory neurons are resistant to apoptosis, yet human foreskin fibroblasts are susceptible: evidence for a cell-type-specific apoptotic response.Herpes simplex virus blocks apoptosis by precluding mitochondrial cytochrome c release independent of caspase activation in infected human epithelial cells.Herpes simplex virus type 1 immediate-early gene expression is required for the induction of apoptosis in human epithelial HEp-2 cellsActivation of ataxia telangiectasia-mutated DNA damage checkpoint signal transduction elicited by herpes simplex virus infection.Herpes simplex virus UL14 protein blocks apoptosis.ICP0 gene expression is a herpes simplex virus type 1 apoptotic triggerp53 and hTERT determine sensitivity to viral apoptosisProtection by herpes simplex virus glycoprotein D against Fas-mediated apoptosis: role of nuclear factor kappaB.Viral oncoapoptosis of human tumor cells.
P2860
Q24305296-C08B54EA-76F7-4728-9A07-926D35A101DDQ24537648-5B1F6008-F4D6-4486-B054-FDAB5C77FD7EQ24657245-C841DCF1-99F6-467C-B16D-E4189CAC2159Q33229421-84FF9C86-4482-450C-94F9-FE0E5158A274Q33558390-7B168F3A-DC13-485D-8C59-DFAAB4CB4AA0Q33763388-333F065B-A9B1-48F4-8E79-1AEB9B726425Q33810337-00251DBE-BD70-4932-9C93-2AB207D180B6Q33815866-4B3D036A-A587-4D9C-BAA8-37FD164892E7Q33843399-FD193B97-0292-4F51-BDD0-98959242EB7AQ34150713-C4C02526-39A1-4CF3-B8EB-876E5AEFD534Q34358232-CA471FA2-7FD8-41D2-AC0F-33D3427D8AC0Q34359278-4E00BBA9-03A8-40BC-A7C3-75CF1B2A399EQ35101393-C1437C36-352A-4E9F-A83F-79958BE585E7Q35149538-43AF7A73-4098-489B-A800-E9B365CAF6AEQ35613809-4F63B2D4-89EA-4A41-83B4-E1CB88FE0C92Q35613819-495F67A9-CE14-4C6C-98E2-370BF02B60F7Q37094247-75CAC6DD-7D58-41EC-9A15-78B49982AEF5Q37099797-2B36BF73-956E-459D-ADF2-A024EA577D65Q37268978-DF10DADE-F9D3-4124-9B4A-F9AD6AC5FB98Q37436473-E7D74AEC-BB36-4224-A0BF-2F8438DA3ABDQ37683123-64E9CC15-8B3A-450C-8979-6724E0299586Q37743180-D3C0686E-7091-42FA-876C-A1192D2C1EA8Q37955947-D7721EA3-DE83-4BDF-9300-50FD670A014AQ39254798-CBC66288-A130-46B3-B154-705BA3780AC5Q39290324-FBDB8B18-FDD3-4E39-9AFD-CDA17D244E2CQ39736755-04830E1D-9035-4122-8843-A8A6BDBDE799Q40173355-E9D7DE12-1D83-4380-A5DA-4BB94FAEE39CQ40212968-52256453-5CAF-47C7-A693-0EECC0CEA5E9Q40377056-9FEA719F-ED44-401D-970A-B49E57FBB562Q40407545-28C30449-9975-4D9A-AD90-8657F96632C2Q40621867-849A0600-954C-41C5-8828-859E70C1DF65Q41495440-90AC3633-F0DB-4745-ACB1-5FF3DB23CDDBQ41846932-B454795A-C610-4FA7-8982-4C4374A4C1F5Q45722712-3CD610FD-B78F-4FE7-901D-A19116AB8A3FQ45864370-1F88F4BE-8E10-4DC2-BA64-D643578EF239
P2860
Accumulation of herpes simplex virus type 1 early and leaky-late proteins correlates with apoptosis prevention in infected human HEp-2 cells.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Accumulation of herpes simplex ...... in infected human HEp-2 cells.
@ast
Accumulation of herpes simplex ...... in infected human HEp-2 cells.
@en
type
label
Accumulation of herpes simplex ...... in infected human HEp-2 cells.
@ast
Accumulation of herpes simplex ...... in infected human HEp-2 cells.
@en
prefLabel
Accumulation of herpes simplex ...... in infected human HEp-2 cells.
@ast
Accumulation of herpes simplex ...... in infected human HEp-2 cells.
@en
P2093
P2860
P1433
P1476
Accumulation of herpes simplex ...... in infected human HEp-2 cells.
@en
P2093
P2860
P304
P356
10.1128/JVI.75.2.1013-1030.2001
P577
2001-01-01T00:00:00Z